Tuberculosis Testing Market

Tuberculosis Testing Market (Test Type - Chest X-Ray, Culture Based Tests, IGRA, Mantoux Test (TST), Nucleic Acid Testing (NAT), Xpert Test, Serological Tests, and Smear Microscopy; End-User - Academics and Research, Hospitals Laboratories, Physician's Office Laboratories, and Reference Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019-2027

  • According to Transparency Market Research’s latest report on the global tuberculosis testing Market for the historical period 2017–2018 and forecast period 2019–2027, Increase in the case detection rate worldwide, Rise in the prevalence of drug-resistant tuberculosis infection, Improvement in bacteriological confirmation, Rise in awareness enabling proper management of the disease, Rising demand for improved and technologically advanced tuberculosis testing procedures and Tuberculosis awareness and control programs are projected to drive the global tuberculosis testing Market during the forecast period
  • According to the report, the global tuberculosis testing Market was valued at US$ 2.5 Bn in 2018 and is anticipated to expand at a CAGR of 4.0% from 2019 to 2027

Request a sample to get extensive insights into the Tuberculosis Testing Market

Increase in the case detection rate worldwide: Key Drivers

  • Case detection rate (CDR) provides approximate indication of percentage of all incident cases of TB that are diagnosed with the help of recommended tests and notified to the national surveillance or the national tuberculosis program (NTP)
  • CDR for a country is calculated as: the total number of new and relapse cases of tuberculosis that were notified ÷ the total number of incident cases estimated for the same year. CDR is expressed as a percentage. CDR is significant in order to know the percentage of incident TB patients that opt for diagnosis every year in a given country.
  • A report titled as ‘Global Tuberculosis Report’ published by the WHO in 2015 stated that, around 10.4 million new (incident) TB cases estimated worldwide

Rise in the prevalence of drug-resistant tuberculosis infection Boost Market Growth

  • Drug-resistant TB spreads through air-borne transmission. It is commonly acquired from a person with drug-resistant tuberculosis infection. It is often a result of misuse or mismanagement of drugs employed for the TB treatment.
  • According to a WHO report, in 2016, six countries accounted for 60% of new TB cases viz. India, Indonesia, China, Nigeria, Pakistan, and South Africa
  • Moreover, around 480,000 new tuberculosis cases reported were mostly multidrug-resistant TB (MDR-TB) cases and around 100,000 patients identified with rifampicin-resistant TB were also eligible for the treatment of MDR-TB
  • This increases the demand for tuberculosis detection and drug susceptibility testing for proper management of susceptible as well as drug-resistant tuberculosis infection worldwide.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Challenges of Mantoux test to Hamper Market

  • Mantoux TST is generally performed by intradermal injection, or injection of purified MTB (Mycobacterium tuberculae) protein or antigen derivative into the skin of the forearm to check for hypersensitivity. Mantoux TST is being considered a gold standard test for latent TB detection; however, its performance is limited by challenges in terms of specificity, sensitivity, and availability of TST antigens.
  • A report published by the WHO (2017) titled ‘Unitaid TB Diagnostics Technology Landscape’ states that Mantoux test is limited by the patient’s age, immune status, and exposure to non-tuberculosis mycobacteria (NTM)
  • Moreover, recent vaccination with Bacillus Calmette-Guérin (BCG) decreases the specificity of Mantoux test significantly, while cut-off for the test is another factor limiting the performance of the overall Mantoux test
  • In addition to these challenges, shortage of supply of TST antigens has been reported in several countries. This is expected to hamper the global tuberculosis testing market during the forecast period.

Global tuberculosis testing Market: Competitive Landscape

  • This report profiles major players in the global tuberculosis testing Market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global tuberculosis testing Market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global tuberculosis testing Market are
    • Thermo Fisher Scientific, Inc.
    • Alere, Inc.
    • Becton
    • Dickinson and Company
    • F. Hoffmann-La Roche AG
    • LIONEX Diagnostics & Therapeutics GmbH
    • Danaher Corporation
    • Danaher Corporation
    • Creative Diagnostics
    • QIAGEN
    • Hain Lifescience GmbH.
    • Oxford Immunotec Ltd.
    • Hologic, Inc.
    • Cepheid
    • Akonni Biosystems, Inc.
    • bioMerieux SA
    • Epistem Ltd.
    • among others

Stuck in a neck-to-neck competition with other brands? Request a custom report on Tuberculosis Testing Market

Global tuberculosis testing Market: Key Developments

Key players in the global tuberculosis testing Market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global tuberculosis testing Market. A few expansion strategies adopted by players operating in the global tuberculosis testing Market are:

  • The Thermo Fisher Scientific, Inc. offers wide range of product portfolio ranging from analytical instruments, automation, robotics, and life science research consumables to clinical diagnostics.
  • The Thermo Fisher Scientific, Inc., more than 40 products are being marketed exclusively for tuberculosis detection, diagnosis, isolation, and identification from a variety of samples such as blood, sputum, urine, tissue, and sterile body fluids
  • By Thermo Fisher Scientific, Inc., for instance, VersaTREK microbial detection system offered by company, enables fully automated detection of mycobacteria from all samples or specimens types. It is also possible to perform accurate Mycobacterium tuberculae susceptibility assays with the same system.
  • Alere, Inc. focuses on enhancing its market presence in developing economies by setting up direct sales channels. In early 2015, the company set up a sales unit in India for effective product sales.
  • Becton, Dickinson and Company launches innovative new products to expand its presence globally. The company conducts its research & development activities in North America, China, France, India, Ireland, and Singapore. It spent approximately US$ 828 Mn on research & development in 2016.
  • BD offers a wide range of products for mycobacterial growth and testing requirements, as well as provides training, technical advice, and services from specimen collection to reporting.
  • F. Hoffmann-La Roche AG is focused on developing new products for the treatment of cancer and respiratory diseases. The company constantly works on improving the product efficiency and patient care. The company has initiated new strategic programs for Africa.
  • Lionex produces, preserves, authenticates, and distributes standard reference microorganisms, diagnostic kits, recombinant proteins, and other materials to public and private sectors and scientific research communities across the world.

The report on the global tuberculosis testing Market discussed individual strategies, followed by company profiles of manufacturers of tuberculosis testing Kits. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global tuberculosis testing Market.

Global Tuberculosis Testing Market – Segmentation

Test Type

  • Chest X-ray
  • Culture-based Tests
  • Interferon-Gamma Release Assay (IGRA)
  • Mantoux Test (TST)
  • Nucleic Acid Testing (NAT), Xpert test
  • Serological Tests
  • Smear Microscopy
  • Other Tests (ADA, etc.)

End-user

  • Academics and Research
  • Hospitals Laboratories
  • Physician's Office Laboratories
  • Reference Laboratories
  • Others (Home Health Agencies, etc.)

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of tuberculosis testing market?

Tuberculosis testing market to Reach US$ 3,399.8 Mn By 2027

What is the anticipated CAGR of the tuberculosis testing market in the forecast period?

Tuberculosis testing market is anticipated to expand at a CAGR of 4.0% from 2019 to 2027

What are the key driving factors for the growth of the tuberculosis testing market?

Tuberculosis testing market is driven by rise in the prevalence of drug-resistant tuberculosis infection

Which region is expected to project the highest market share in the global tuberculosis testing market?

North America accounted for a major share of the global tuberculosis testing market and the trend is anticipated to continue during the forecast period

Who are the key players in the global tuberculosis testing market?

Key players in the global tuberculosis testing market include Thermo Fisher Scientific, Inc., Alere, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche AG

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global tuberculosis testing market

    4. Market Overview

        4.1. Introduction

            4.1.1. Test Type Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Tuberculosis Testing Market Analysis and Forecast, 2017–2027

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Burden of TB Worldwide

        5.2.  Burden of MDR-TB Worldwide

        5.3. Challenges of Traditional Testing/Diagnostic Methods

        5.4. Mergers & Acquisitions

    6. Global Tuberculosis Testing Market Analysis and Forecast, by Test Type

        6.1. Introduction & Definition

            6.1.1. Key Findings / Developments

        6.2. Global Tuberculosis Testing Market Value Forecast, by Test Type, 2017–2027

            6.2.1. Chest X-Ray

            6.2.2. Culture Based Tests

            6.2.3. Interferon-Gamma Release Assays (IGRA)

            6.2.4. Mantoux Test (TST)

            6.2.5. Nucleic Acid Testing (NAT), Xpert test

            6.2.6. Serological Tests

            6.2.7. Smear Microscopy

            6.2.8. Other Tests (ADA, etc.)

        6.3. Global Tuberculosis Testing Market Attractiveness, by Test Type

    7. Global Tuberculosis Testing Market Analysis and Forecast, by End-user

        7.1. Introduction & Definition

            7.1.1. Key Findings / Developments

        7.2. Global Tuberculosis Testing Market Value Forecast, by End-user, 2017–2027

            7.2.1. Hospitals Laboratories

            7.2.2. Reference Laboratories    

            7.2.3. Physician’s Office Laboratories

            7.2.4. Academics and Research    

            7.2.5. Others (Home Health Agencies, etc.)

        7.3. Global Tuberculosis Testing Market Attractiveness, by End-user

    8. Global Tuberculosis Testing Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Global Tuberculosis Testing Market Value Forecast, by Region

            8.2.1. North America

            8.2.2. Europe

            8.2.3. Asia Pacific

            8.2.4. Latin America

            8.2.5. Middle East & Africa

        8.3. North America Tuberculosis Testing Market Attractiveness, by Region

    9. North America Tuberculosis Testing Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. North America Tuberculosis Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

            9.2.1. Chest X-Ray

            9.2.2. Culture Based Tests

            9.2.3. Interferon-Gamma Release Assays (IGRA)

            9.2.4. Mantoux Test (TST)

            9.2.5. Nucleic Acid Testing (NAT), Xpert test

            9.2.6. Serological Tests

            9.2.7. Smear Microscopy

            9.2.8. Other Tests (ADA, etc.)

        9.3. North America Tuberculosis Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027

            9.3.1. Hospitals Laboratories

            9.3.2. Reference Laboratories    

            9.3.3. Physician’s Office Laboratories

            9.3.4. Academics and Research    

            9.3.5. Others (Home Health Agencies, etc.)

        9.4. North America Tuberculosis Testing Market Value (US$ Mn) Forecast, by Country, 2017–2027

            9.4.1. U.S.

            9.4.2. Canada

        9.5. North America Tuberculosis Testing Market Attractiveness Analysis

            9.5.1. By Test Type

            9.5.2. By End-user

            9.5.3. By Country

    10. Europe Tuberculosis Testing Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Europe Tuberculosis Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

            10.2.1. Chest X-Ray

            10.2.2. Culture Based Tests

            10.2.3. Interferon-Gamma Release Assays (IGRA)

            10.2.4. Mantoux Test (TST)

            10.2.5. Nucleic Acid Testing (NAT), Xpert test

            10.2.6. Serological Tests

            10.2.7. Smear Microscopy

            10.2.8. Other Tests (ADA, etc.)

        10.3. Europe Tuberculosis Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027

            10.3.1. Hospitals Laboratories

            10.3.2. Reference Laboratories    

            10.3.3. Physician’s Office Laboratories

            10.3.4. Academics and Research    

            10.3.5. Others (Home Health Agencies, etc.)

        10.4. Europe Tuberculosis Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            10.4.1. Germany

            10.4.2. U.K.

            10.4.3. France

            10.4.4. Spain

            10.4.5. Italy

            10.4.6. Rest of Europe

        10.5. Europe Tuberculosis Testing Market Attractiveness Analysis

            10.5.1. By Test Type

            10.5.2. By End-user

            10.5.3. By Country/Sub-region

    11. Asia Pacific Tuberculosis Testing Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Asia Pacific Tuberculosis Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

            11.2.1. Chest X-Ray

            11.2.2. Culture Based Tests

            11.2.3. Interferon-Gamma Release Assays (IGRA)

            11.2.4. Mantoux Test (TST)

            11.2.5. Nucleic Acid Testing (NAT), Xpert test

            11.2.6. Serological Tests

            11.2.7. Smear Microscopy

            11.2.8. Other Tests (ADA, etc.)

        11.3. Asia Pacific Tuberculosis Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027

            11.3.1. Hospitals Laboratories

            11.3.2. Reference Laboratories    

            11.3.3. Physician’s Office Laboratories

            11.3.4. Academics and Research    

            11.3.5. Others (Home Health Agencies, etc.)

        11.4. Asia Pacific Tuberculosis Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            11.4.1. China

            11.4.2. Japan

            11.4.3. India

            11.4.4. Australia & New Zealand

            11.4.5. Rest of Asia Pacific

        11.5. Asia Pacific Tuberculosis Testing Market Attractiveness Analysis

            11.5.1. By Test Type

            11.5.2. By End-user

            11.5.3. By Country/Sub-region

    12. Latin America Tuberculosis Testing Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Latin America Tuberculosis Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

            12.2.1. Chest X-Ray

            12.2.2. Culture Based Tests

            12.2.3. Interferon-Gamma Release Assays (IGRA)

            12.2.4. Mantoux Test (TST)

            12.2.5. Nucleic Acid Testing (NAT), Xpert test

            12.2.6. Serological Tests

            12.2.7. Smear Microscopy

            12.2.8. Other Tests (ADA, etc.)

        12.3. Latin America Tuberculosis Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027

            12.3.1. Hospitals Laboratories

            12.3.2. Reference Laboratories    

            12.3.3. Physician’s Office Laboratories

            12.3.4. Academics and Research    

            12.3.5. Others (Home Health Agencies, etc.)

        12.4. Latin America Tuberculosis Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            12.4.1. Brazil

            12.4.2. Mexico

            12.4.3. Rest of Latin America Latin America

        12.5. Latin America Tuberculosis Testing Market Attractiveness Analysis

            12.5.1. By Test Type

            12.5.2. By End-user

            12.5.3. By Country/Sub-region

    13. Middle East & Africa Tuberculosis Testing Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Middle East & Africa Tuberculosis Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

            13.2.1. Chest X-Ray

            13.2.2. Culture Based Tests

            13.2.3. Interferon-Gamma Release Assays (IGRA)

            13.2.4. Mantoux Test (TST)

            13.2.5. Nucleic Acid Testing (NAT), Xpert test

            13.2.6. Serological Tests

            13.2.7. Smear Microscopy

            13.2.8. Other Tests (ADA, etc.)

        13.3. Middle East & Africa Tuberculosis Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027

            13.3.1. Hospitals Laboratories

            13.3.2. Reference Laboratories    

            13.3.3. Physician’s Office Laboratories

            13.3.4. Academics and Research    

            13.3.5. Others (Home Health Agencies, etc.)

        13.4. Middle East & Africa Tuberculosis Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            13.4.1. GCC Countries

            13.4.2. South Africa

            13.4.3. Rest of Middle East & Africa

        13.5. Middle East & Africa Tuberculosis Testing Market Attractiveness Analysis

            13.5.1. By Test Type

            13.5.2. By End-user

            13.5.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Market Player - Competition Matrix (by Tier and Size of companies)

        14.2. Market Share / Position Analysis, by Company, 2018

        14.3. Competitive Business Strategies

        14.4. Company Profiles

            14.4.1. Thermo Fisher Scientific, Inc.

                14.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.1.2. Growth Strategies

                14.4.1.3. SWOT Analysis

            14.4.2. Alere, Inc.

                14.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.2.2. Growth Strategies

                14.4.2.3. SWOT Analysis

            14.4.3. Becton, Dickinson and Company

                14.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.3.2. Growth Strategies

                14.4.3.3. SWOT Analysis

            14.4.4. F. Hoffmann-La Roche AG

                14.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.4.2. Growth Strategies

                14.4.4.3. SWOT Analysis

            14.4.5. LIONEX Diagnostics & Therapeutics GmbH.

                14.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.5.2. Growth Strategies

                14.4.5.3. SWOT Analysis

            14.4.6. Danaher Corporation

                14.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.6.2. Growth Strategies

                14.4.6.3. SWOT Analysis

            14.4.7. Creative Diagnostics

                14.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.7.2. Growth Strategies

                14.4.7.3. SWOT Analysis

            14.4.8. QIAGEN

                14.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.8.2. Growth Strategies

                14.4.8.3. SWOT Analysis

            14.4.9. Hain Lifescience GmbH.

                14.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.9.2. Growth Strategies

                14.4.9.3. SWOT Analysis

            14.4.10. Oxford Immunotec Ltd.

                14.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.10.2. Growth Strategies

                14.4.10.3. SWOT Analysis

            14.4.11. Hologic, Inc.

                14.4.11.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.11.2. Growth Strategies

                14.4.11.3. SWOT Analysis

            14.4.12. Cepheid

                14.4.12.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.12.2. Growth Strategies

                14.4.12.3. SWOT Analysis

            14.4.13. Akonni Biosystems, Inc.

                14.4.13.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.13.2. Growth Strategies

                14.4.13.3. SWOT Analysis

            14.4.14. bioMerieux SA

                14.4.14.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.14.2. Growth Strategies

                14.4.14.3. SWOT Analysis

            14.4.15. Epistem Ltd

                14.4.15.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.15.2. Growth Strategies

                14.4.15.3. SWOT Analysis

    List of Table

    Table 01:Top 10 High TB burden countries with estimated number of new TB cases globally

    Table 02:Estimated number of MDR-TB among all notified TB cases in high burden countries (2018)

    Table 03:TB R&D Funders by Rank in 2018

    Table 04:Tuberculosis Diagnostics tests Pipeline

    Table 05:Global Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2027

    Table 06:Global Tuberculosis Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 07:Global Tuberculosis Testing Market Size (US$ Mn) Forecast, by Region, 2017–2027

    Table 08:North America Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2017–2027

    Table 09:North America Tuberculosis Testing Market Size (US$ Bn) Forecast, by Test Type, 2017–2027

    Table 10:North America Tuberculosis Testing Market Size (US$ Bn) Forecast, by End-User, 2017–2027

    Table 11:Europe Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2017–2027

    Table 12:Europe Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2027

    Table 13:Europe Tuberculosis Testing Market Size (US$ Bn) Forecast, by End-User, 2017–2027

    Table 14:Asia Pacific Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2017–2027

    Table 15:Asia Pacific Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2027

    Table 16:Asia Pacific Tuberculosis Testing Market Size (US$ Mn) Forecast, by End-User, 2017–2027

    Table 17:Latin America Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2017–2027

    Table 18:Latin America Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2027

    Table 19:Latin America Tuberculosis Testing Market Size (US$ Mn) Forecast, by End-User, 2017–2027

    Table 20:Middle East and Africa Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2017–2027

    Table 21:Middle East and Africa Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2027

    Table 22:Middle East and Africa Tuberculosis Testing Market Size (US$ Mn) Forecast, by End-User, 2017–2027

    List of Figure

    Figure 01:Global Tuberculosis Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2018-2027

    Figure 02:Market Value Share, by Test Type (2018)

    Figure 03:Market Value Share, by End User (2018)

    Figure 04:Market Value Share, by Region (2018)

    Figure 05:Annual Global Plan Research Funding Targets versus 2015 Funding on Tuberculosis

    Figure 06:Total TB R&D Funding, 2005–2015

    Figure 07:Total TB R&D Funding by Funder Category, 2015

    Figure 08:Total TB R&D Funding by Funder Category, 2005–2015 (Mn)

    Figure 09:Global Tuberculosis Testing Market Value Share Analysis, by Test Type, 2018 and 2027

    Figure 10:Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Chest X-Ray, 2017–2027

    Figure 11:Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Culture Based Tests,

    Figure 12:Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by IGRA, 2017–2027

    Figure 13:Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Mantoux test (TST), 2017–2027

    Figure 14:Global Tuberculosis Testing Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Nucleic Acid Testing (NAT), Xpert test, 2017–2027

    Figure 15:Global Tuberculosis Testing Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Serological Tests,

    Figure 16:Global Tuberculosis Testing Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Smear Microscopy, 2017–2027

    Figure 17:Global Tuberculosis Testing Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Other Tests (ADA, etc.), 2017–2027

    Figure 18:Global Tuberculosis Testing Market Attractiveness, by Test Type, 2017-2025

    Figure 19:Global Tuberculosis Testing Market Value Share Analysis, by End-User, 2018 and 2027

    Figure 20:Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2027

    Figure 21:Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Reference Laboratories, 2017–2027

    Figure 22:Europe Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Physician’s Office Laboratories, 2017–2027

    Figure 23:Europe Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Academics and Research, 2017–2027

    Figure 24:Europe Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

    Figure 25:Global Tuberculosis Testing Market Attractiveness, by End-User, 2017-2025

    Figure 26:Global Tuberculosis Testing Market Revenue (US$ Bn) Forecast, 2017–2027

    Figure 27:Global Tuberculosis Testing Market Value Share Analysis, by Region, 2018 and 2027

    Figure 28:Global Tuberculosis Testing Market Attractiveness, by Region, 2017-2025

    Figure 29:North America Tuberculosis Testing Market Size (US$ Bn) and Y-o-Y Growth (%) Forecast, 2017–2027

    Figure 30:North America Tuberculosis Testing Market Attractiveness Analysis, by Country, 2018-2027

    Figure 31:North America Tuberculosis Testing Market Value Share Analysis, by Country, 2018 and 2027

    Figure 32:North America Tuberculosis Testing Market Value Share Analysis, by Test Type, 2018 and 2027

    Figure 33:North America Tuberculosis Testing Market Value Share Analysis, by End-User, 2018 and 2027

    Figure 34:North America Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2018-2027

    Figure 35:North America Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2018-2027

    Figure 36:Europe Tuberculosis Testing Market Size (US$ Bn) Forecast, 2017–2027

    Figure 37:Europe Market Attractiveness Analysis, by Country, 2018-2027

    Figure 38:Europe Tuberculosis Testing Market Value Share Analysis, by Country, 2018 and 2027

    Figure 39:Europe Tuberculosis Testing Market Value Share Analysis, by Test Type, 2018 and 2027

    Figure 40:Europe Tuberculosis Testing Market Value Share Analysis, by End-User, 2018 and 2027

    Figure 41:Europe Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2018-2027

    Figure 42:Europe Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2018-2027

    Figure 43:Asia Pacific Tuberculosis Testing Market Size (US$ Mn)  and Y-o-Y Growth (%) Forecast, 2017–2027

    Figure 44:Asia Pacific Tuberculosis Testing Market Attractiveness Analysis, by Country, 2018-2027

    Figure 45:Asia Pacific Tuberculosis Testing Market Value Share Analysis, by Country, 2018 and 2027

    Figure 46:Asia Pacific Tuberculosis Testing Market Value Share Analysis, by Test Type, 2018 and 2027

    Figure 47:Asia Pacific Tuberculosis Testing Market Value Share Analysis, by End-User, 2018 and 2027

    Figure 48:Asia Pacific Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2018-2027

    Figure 49:Asia Pacific Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2018-2027

    Figure 50:Latin America Tuberculosis Testing Market Size (US$ Mn)  and Y-o-Y Growth (%) Forecast, 2017–2027

    Figure 51:Latin America Tuberculosis Testing Market Attractiveness Analysis, by Country, 2018-2027

    Figure 52:Latin America Tuberculosis Testing Market Value Share Analysis, by Country, 2018 and 2027

    Figure 53:Latin America Tuberculosis Testing Market Value Share Analysis, by Test Type, 2018 and 2027

    Figure 54:Latin America Tuberculosis Testing Market Value Share Analysis, by End-User, 2018 and 2027

    Figure 55:Latin America Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2018-2027

    Figure 56:Latin America Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2018-2027

    Figure 57:Middle East and Africa Tuberculosis Testing Market Size (US$ Mn)  and Y-o-Y Growth (%) Forecast, 2017–2027

    Figure 58:Middle East and Africa Tuberculosis Testing Market Attractiveness Analysis, by Country, 2018-2027

    Figure 59:Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by Country, 2018 and 2027

    Figure 60:Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by Test Type, 2018 and 2027

    Figure 61:Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by End-User, 2018 and 2027

    Figure 62:Middle East and Africa Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2018-2027

    Figure 63:Middle East and Africa Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2018-2027

    Figure 64:Thermo Fisher Scientific, Inc.- Breakdown of Net Sales (% Share), by Business segments (2018)

    Figure 65:Thermo Fisher Scientific, Inc.-  Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 66:Alere, Inc.- Revenue Split, by Operating Segment, 2015

    Figure 67:Alere, Inc. - Total Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2018

    Figure 68:Becton, Dickinson and Company - Breakdown of Net Sales, by Region, 2018

    Figure 69:Becton, Dickinson and Company- Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 70:F. Hoffmann-La Roche AG Breakdown of Net Sales (Pharmaceutical Division), by Region, 2015

    Figure 71:F. Hoffmann-La Roche AG- Revenue (US$ Bn) & Y-o-Y Growth (%), 2015–2018

    Figure 72:Danaher Corporation - Breakdown of Revenue, by Region, 2018

    Figure 73:Danaher Corporation - Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2018

    Figure 74:QIAGEN- Breakdown of Net Sales, by Business Segment, 2018

    Figure 75:QIAGEN- Revenue (US$ Bn) and Y-o-Y Growth (%), 2015–2018

    Figure 76:Oxford Immunotec Ltd.- Breakdown of Net Sales, by region, 2015

    Figure 77:Oxford Immunotec Ltd. - Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018

    Figure 78: Hologic, Inc. - Breakdown of Net Sales, by Country/Region, 2015

    Figure 79:Hologic, Inc. - Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 80:Cepheid - Breakdown of Net Sales, by Country/Region, 2015

    Figure 81:Cepheid - Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 82:bioMerieux SA - Breakdown of Net Sales, by Country/Region, 2018

    Figure 83:bioMerieux SA - Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 84:Epistem Ltd. - Breakdown of Net Sales, by Country/Region, 2015

    Figure 85:Epistem Ltd. - Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Copyright © Transparency Market Research, Inc. All Rights reserved